Suppr超能文献

对采用膝下石膏固定的踝关节骨折患者进行口服血栓预防。

Oral thromboprophylaxis in patients with ankle fractures immobilized in a below the knee cast.

作者信息

Haque S, Davies M B

机构信息

Sheffield Teaching Hospitals NHS Trust, Herries Road, Sheffield S5 7AU, United Kingdom.

Sheffield Teaching Hospitals NHS Trust, Herries Road, Sheffield S5 7AU, United Kingdom.

出版信息

Foot Ankle Surg. 2015 Dec;21(4):266-8. doi: 10.1016/j.fas.2015.02.002. Epub 2015 Feb 21.

Abstract

BACKGROUND

Lower-limb immobilization has been implicated as an etiologic factor for a venous thromboembolism (VTE). Most of the current literature encourages the use of thromboprophylaxis with injectable low-molecular-weight heparin (LMWH) in trauma patients. Injectable anticoagulants have inherent problems of producing pain and bruising. They are also difficult to administer, leading to low compliance. Oral anticoagulants are therefore gaining popularity for use as thromboprophylactic agents in hip and knee arthroplasty patients. There are not enough studies in the literature, however, to support their use in ambulatory trauma patients whose ankle fractures are being managed nonoperatively on an outpatient basis.

METHODS

This study evaluated the efficacy of oral anticoagulants for preventing VTE in ambulatory trauma patients who required temporary lower limb immobilization for non-operative management of their ankle fractures. A total of 200 consecutive patients who presented to the fracture clinic with an ankle fracture that was managed in a plaster cast were included in this study. These patients were assessed for risk of developing VTE and high risk patients were administered an oral anticoagulant to prevent VTE.

RESULTS

There was only one case of an isolated distal DVT among the 200 patients.

CONCLUSIONS

This study shows that an oral anticoagulant was a safe alternative to injectable LMWH as a thromboprophylactic agent for ambulatory trauma patients requiring temporary lower limb immobilization for non-operative management of an ankle fracture.

摘要

背景

下肢固定被认为是静脉血栓栓塞症(VTE)的一个病因。目前大多数文献鼓励在创伤患者中使用注射用低分子量肝素(LMWH)进行血栓预防。注射用抗凝剂存在引起疼痛和瘀伤的固有问题。它们也难以给药,导致依从性低。因此,口服抗凝剂在髋关节和膝关节置换术患者中作为血栓预防药物越来越受欢迎。然而,文献中没有足够的研究支持在门诊非手术治疗踝关节骨折的非卧床创伤患者中使用口服抗凝剂。

方法

本研究评估了口服抗凝剂在需要临时下肢固定以非手术方式治疗踝关节骨折的非卧床创伤患者中预防VTE的疗效。本研究共纳入了200例连续到骨折门诊就诊、踝关节骨折采用石膏固定治疗的患者。对这些患者进行VTE发生风险评估,高危患者给予口服抗凝剂以预防VTE。

结果

200例患者中仅1例发生孤立性远端深静脉血栓(DVT)。

结论

本研究表明,对于因非手术治疗踝关节骨折而需要临时下肢固定的非卧床创伤患者,口服抗凝剂作为血栓预防药物是注射用LMWH的一种安全替代药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验